Arkolith/Insider Trading/NMTC/Form 4

Wambeke David J.

Chief Business OfficerNEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) · full profile →Form 4 · filed Mar 3, 2026
Net Buying
Open-Market Buys
$670K
Open-Market Sells
$0
Net Open-Market Flow
$670K
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 1, 2026Buy(P)1.0M$0.67$670K1.0M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 1, 2026Grant(A)500K—$0500K

Transaction Codes

P
Open-market purchase
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001971798-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML